California Governor Newsom's pivotal Prop 50 victory boosts his national profile, but faces criticism over misleading claims and environmental concerns.
Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
California Governor Newsom's pivotal Prop 50 victory boosts his national profile, but faces criticism over misleading claims and environmental concerns.
Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.